Reinfuse Chyme,
Help the Patient

The InsidesTM Company is a leading provider of therapeutic Chyme Reinfusion solutions for the management of High-Output Enteroatmospheric Fistulas and High-Output Enterostomies.

Learn More

Latest News

… Read More of The Insides Company News & Press Release

Breakthrough Device Designation (BDD) Granted by the United States Food and Drug Administration (FDA)

Received the New Zealand Stock Exchange (NZX) Early Stage Companies Award in the 2019 TIN Report

People’s Choice for Best Project Award

Awarded the Innovative Research and Development Grant

Chyme Reinfusion enables oral feeding to recommence to accelerate recovery.

Chyme contains important nutrients and fluids that are traditionally lost when the stoma bag is emptied or discarded. For patients with high-ouput enteroatmospheric fistulas and high-output enterostomies, this can lead to serious complications including:

Hospital readmission
Delays or changes to chemotherapy
Increased risk of clostridium difficile

Patients who lose large volumes of chyme may require parenteral nutrition to maintain hydration and replace electrolytes. However, this is expensive and introduces new risks, including line sepsis, vascular damage and liver diseases.

Chyme Reinfusion is the new standard.

Using The InsidesTM Systemfi to return chyme via the distal stoma restores the patient’s natural bowel continuity.

This can improve:

Electrolyte balance
Liver function

Studies have shown that restoring bowel continuity in patients on parenteral nutrition allowed them to return to an oral diet.

“Chyme re-feeding reduces recovery time, while minimising harms attributed to a de-functioned colon”

Associate Professor Greg O’Grady